Human pancreatic cancer cell lines express the CCKB receptor

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 472-478

  De Weerth, Andreas ^a   Von Schrenck, T ^a   Lohr M ^b   Mirau, S ^a   Greten, H ^a   Kalthoff, H ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Universitat Hamburg ^*

Author keywords

CCKB receptor; Pancreas; Pancreatic cancer

Indexed keywords

BETA ACTIN; CHOLECYSTOKININ RECEPTOR; COMPLEMENTARY DNA; DEOXYRIBONUCLEASE; MESSENGER RNA; OLIGONUCLEOTIDE; RNA;

ARTICLE; BRAIN; CANCER CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITOMETRY; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PANCREAS DUCT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; STOMACH;

ADENOCARCINOMA; BLOTTING, SOUTHERN; DNA, NEOPLASM; HUMANS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, CHOLECYSTOKININ; TUMOR CELLS, CULTURED;

EID: 0033036180     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. 1 Jensen RT, von Schrenck T, Yu D-H, Wank SA, Gardner JD: Pancreatic cholecystokinin (CCK) receptors comparison with other classes of CCK receptors. In: Hughes J, Dockray G, Woodruff G (Eds.). The Neuropcptide Cholecystokinin (CCK). Anatomy and Biochemistry, Receptors, Pharmacology and Physiology. London: Ellis Horwood Limited, 1989; pp. 150-162.
2. 2 Niederau C, Niederau M, Williams JA, Grendell JH: New proglumide-analoque CCK receptor antagonists: very potent and selective for peripheral tissues. Am J Physiol 1986; 251:G839-G860.
3. 3 Niederau C, Faber S, Karaus M: Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome. Gastroenterol 1992; 102:1889-1898.
4. 4 Niederau C, Luethen R, Heintges T: Effects of CCK on pancreatic function and morphology. Ann NY Acad Sci 1994; 98:180-198.
5. 5 Jensen RT, Lemp GF, Gardner JD: Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci USA 1980; 77:2079-2083.
6. 6 Hildebrand P, Drewe J, Luo H, Ketterer S, Gyr K, Beglinger C: Role of cholecystokinin in mediating GRP-stimulated gastric, biliary and pancreatic functions in man. Regul Pept 1992; 41:119-129.
7. 7 Gardner JD, Jensen RT: Secretagogue receptors on pancreatic acinar cells. In: Johnson LR, Christensen J, Jacobson ED, Jackson LJ, Walsh JH (Eds.). Physiology of the Gastrointestinal Tract. 2nd Edition. New York: Raven Press; 1987; pp. 1109-1127.
8. 8 Barrowman JA: The tropic action of gastro-intestinal hormones. Digestion 1975; 12:92-104.
9. 9 Chu M, Borch K, Lilja I, Blomqvist L, Rehfeld JF, Ihse I: Endogenous hypercholecystokininemia model in the hamster: trophic effect on the exocrine pancreas. Pancreas 1992; 7:220-225.
10. 10 Smith JP, Yelamarty RV, Kramer ST, Cheung JY: Effects of cholecystokinin on cytosolic calcium in pancreatic duct segments and ductal cells. Am J Physiol 1993; 83:G1177-1183.
11. 11 Smith JP, Rickabaugh CA, McLaughlin PJ, Zagon IS: Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. Am J Physiol 1993; 55:G149-155.
12. 12 Ishizuka J, Martinez J, Townsend CJ, Thompson JC: The effect of gastrin on growth of human stomach cancer cells. Ann Surg 1992; 215:528-534.
13. 13 Karsenty L, Hajri A, Aprahamian M, Garaud JC, Doffoel M, Damge C: Inhibition of growth of a transplanted rat pancreatic acinar carcinoma with CCK-8. Pancreas 1993; 8:204-211.
14. 14 Hoosein NM, Kiener PA, Curry RC, Brattain MG: Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res 1990; 186:15-21.
15. 15 Sethi T, Rozengurt E: Gastrin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer cells. Cancer Res 1992; 52:6031-6035.
16. 16 Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RJ: Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Cancer Res 1993; 53:3925-3929.
17. 17 Piontek MK, Hengels KJ: Differential mode of action of high-and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin-responsive human gastric adenocarcinoma cells in vitro. Anticancer Res 1993; 13:715-720.
18. 18 Watson S, Durrant L, Elston P, Morris D: Inhibitory effects of the gastrin receptor antagonist (L-365,260) on gastrointestinal tumor cells. Cancer 1991; 68:1255-1260.
19. 19 Watson SA, Crosbee DM, Morris DL, Robertson JF, Makovec F, Rovati LC: Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth. Brit J Cancer 1992; 65:879-883.
20. 20 Wank SA, Pisegna JR, deWeerth A: Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human. Ann NY Acad Sci 1994; 713:49-66.
21. 21 Wank SA, Pisegna JR, deWeerth A: Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Nat Acad Sci USA 1992; 89:8691-8695.
22. 22 Wank SA, Harkins R, Jensen RT, Shapira H, deWeerth A, Slattery T: Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 1992; 89:3125-3129.
23. 23 Kopin AS, Lee YM, McBride EW, Miller LJ, Lu M, Kolakowski LF Jr., Beiborn M: Expression cloning and characterisation of the canine parietal cell gastrin receptor. Proc Nat Acad Sci USA 1992; 89:3605-3609.
24. 24 von Schrenck T, Moran TH, Heinz-Erian P, Gardner JD, Jensen RT: Cholecystokinin receptors on gallbladder muscle and on pancreatic acinar cells: a comparative study. Am J Physiol 1988; 255:G512-G521.
25. 25 Jensen RT, Lemp GF, Gardner JD: Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas. J Biol Chem 1982; 257:5554-5559.
26. 26 Jensen RT, Yu D-H, Gardner JD: Interaction of Cholecystokinin Receptor Antagonists. In: Wang RY, Schoenfeld R (Eds.). Cholecystokinin Receptor Antagonists. New York: Alan R. Liss, Incorporated; 1988; pp. 53-72.
27. 27 Lee YM, Beinborn M, McBride EW, Lu M, Kolakowski LJ, Kopin AS: The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem 1993; 268:8164-8169.
28. 28 Pisegna JR, deWeerth A, Huppi K, Wank SA: Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem Biophys Res Com 1992; 189:296-303.
29. 29 Song I, Brown DR, Wiltshire RN, Gantz I, Trent JM, TY: The human gastrin/ Cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. Proc Natl Acad Sci USA 1993; 90:9085-9089.
30. 30 Trautmann B, Schlitt HJ, Hahn EG, Loehr M: Isolation, culture, and characterisation of pancreatic duct cells. Pancreas 1993; 8:248-254.
31. 31 Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbour, NY, 1982.
32. 32 Han JH, Stratowa C, Rutter WJ: Isolation of full-length putative rat lysophospholipase cDNA using improved methods for mRNA isolation and cDNA cloning. Biochemistry 1987; 26:1617-1625.
33. 33 Nakayima-Lijima H, Kamada H, Reddy P, Kakanuga T: Molecular structure of the human cytoplasmatic Beta-actin gene interspecies homology of the introns. Proc Natl Acad Sci USA 1983; 82:6133-6137.
34. 34 Honda T, Wada E, Battey JF, Wank SA: Differential expression of CCKA and CCKB receptors in the rat brain. Mol Cell Neurosci 1993; 4:143-154.
35. 35 de Weerth A, Pisegna JR, Wank SA: The CCK-A receptor in gallbladder and pancreas are identical: Molecular cloning and expression. Am J Physiol 1992; 265(6 Pt1):G1116-1121.
36. 36 de Weerth A, Pisegna JR, Huppi K, Wank SA: Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem Biophys Res Com 1993; 194:811-818.
37. 37 de Weerth A, Pisegna J, Wank S: Molecular cloning of the guinea pig CCK-B receptor from gallbladder. Gastroenterol 1993; 104:A497.
38. 38 Lignon MF, Bernad N, Martinez J: Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line. Eur J Pharmacol 1993; 245:241-246.
39. 39 Jensen RT, Qian JM, Lin JT, Mantey SA, Pisegna JR, Wank SA: Distinguishing multiple CCK receptor subtypes. Studies with guinea pig chief cells and transfected human CCK receptors. Ann NY Acad Sci 1994; 713:88-106.
40. 40 Smith JP, Liu G, Soundararajan V, McLaughlin PJ, Zagon IA: Identification and characterisation of CCK-B/gastrin receptors in human pancreatic cell lines. Am J Physiol, 1994; 288:R277-R283.
41. 41 Zhou W, Povoski SP, Longnecker DS, Bell RJ: Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Cancer Res 1992; 52:6905-6911.
42. 42 Watson S, Steele R: Gastrin receptors on gastrointestinal tumor cells. In: Gastrin receptors in Gastrointestinal tumors. Austin, TX:CRC 1993; pp. 20-35.
43. 43 Johnson L: Effect of gastrointestinal hormones on pancreatic growth. Cancer 1981; 47:1640-1647.
44. 44 Dembinski A, Warzecha Z, Konturek SJ, Banas M, Cai RZ, Schally AV: The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas. J Physiol Pharmacol 1991; 42:263-277.
45. 45 Frucht H, Gazdar AF, Park JA, Oie H, Jensen RT: Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 1992; 52:1114-1122.
46. 46 Smith JP, Solomon TE, Bagheri S, Kramer S: Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci 1990; 35:1377-1384.
47. 47 Smith JP, Fantaskey AP, Gouzhen L, Zagon IS: Identification of gastrin as a growth peptide in human pancreatic cancer. Am J Physiol 1995; 268:R135-R141.
48. 48 Smith J, Kramer ST, Solomon TE: CCK stimulates growth of six human pancreatic cell lines in serum free medium. Regul Peptid 1991; 32:341-349.